Literature DB >> 25522185

Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system.

Lidia Daimiel-Ruiz1, Mercedes Klett-Mingo, Valentini Konstantinidou, Victor Micó, Juan F Aranda, Belén García, Javier Martínez-Botas, Alberto Dávalos, Carlos Fernández-Hernando, Jose M Ordovás.   

Abstract

SCOPE: The increased prevalence of cardiovascular diseases (CVDs) has been hypothesized to be the result of an increased exposure to a host of atherogenic environmental factors, paramount among them being unhealthy dietary habits. Long-chain n-3 polyunsaturated fatty acids have been shown to have cardio protective effects, partially due to their ability to regulate gene expression. In this regard, increasing attention has been devoted to the role of miRNAs as regulators of multiple metabolic pathways whose deregulation has been associated with CVD risk. METHODS AND
RESULTS: In this work, we investigated whether miRNA expression was regulated by docosahexanoic acid, conjugated linoleic acid, and cholesterol in Caco-2 cells. The modulated miRNAs, miR-107 was differentially expressed by all treatments and this modulation was independent of its hosting gene, PANK1, possibly through its own promoter, which contains binding sites for metabolically relevant transcription factors. Among the putative target genes of miR-107, we found some genes with key roles in circadian rhythm. Specifically, we demonstrated that binding of miR-107 to the CLOCK gene results in the deregulation of the circadian rhythm of the cells.
CONCLUSION: Since chronodisruption has been linked to metabolic disorders such as type 2 diabetes, atherosclerosis, obesity, and CVD, our findings suggests that miR-107 could represent a new approach for pharmacological treatment of these diseases.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Circadian rhythm; DHA; Dietary lipids; miR-107

Mesh:

Substances:

Year:  2015        PMID: 25522185      PMCID: PMC4591752          DOI: 10.1002/mnfr.201400616

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  72 in total

1.  Discordant expression of miR-103/7 and pantothenate kinase host genes in mouse.

Authors:  Brenda J Polster; Shawn K Westaway; Thuy M Nguyen; Moon Y Yoon; Susan J Hayflick
Journal:  Mol Genet Metab       Date:  2010-08-04       Impact factor: 4.797

2.  Comprehensive analysis of microRNA-mRNA co-expression in circadian rhythm.

Authors:  Young Ji Na; Jung Hwan Sung; Suk Chan Lee; Young Ju Lee; Yeun Joo Choi; Woong Yang Park; Hee Sup Shin; Ju Han Kim
Journal:  Exp Mol Med       Date:  2009-09-30       Impact factor: 8.718

Review 3.  Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.

Authors:  Jennifer G Robinson; Neil J Stone
Journal:  Am J Cardiol       Date:  2006-05-30       Impact factor: 2.778

Review 4.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

5.  Pantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted state.

Authors:  Roberta Leonardi; Jerold E Rehg; Charles O Rock; Suzanne Jackowski
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

6.  Circadian timing of food intake contributes to weight gain.

Authors:  Deanna M Arble; Joseph Bass; Aaron D Laposky; Martha H Vitaterna; Fred W Turek
Journal:  Obesity (Silver Spring)       Date:  2009-09-03       Impact factor: 5.002

Review 7.  Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways.

Authors:  Bernard R Wilfred; Wang-Xia Wang; Peter T Nelson
Journal:  Mol Genet Metab       Date:  2007-05-22       Impact factor: 4.797

8.  Promoter analysis of the DHCR24 (3β-hydroxysterol Δ(24)-reductase) gene: characterization of SREBP (sterol-regulatory-element-binding protein)-mediated activation.

Authors:  Lidia A Daimiel; María E Fernández-Suárez; Sara Rodríguez-Acebes; Lorena Crespo; Miguel A Lasunción; Diego Gómez-Coronado; Javier Martínez-Botas
Journal:  Biosci Rep       Date:  2012-12-06       Impact factor: 3.840

9.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

10.  Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data.

Authors:  David L Corcoran; Kusum V Pandit; Ben Gordon; Arindam Bhattacharjee; Naftali Kaminski; Panayiotis V Benos
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more
  14 in total

1.  Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels.

Authors:  Sandra Van der Auwera; Sabine Ameling; Katharina Wittfeld; Enrique d'Harcourt Rowold; Matthias Nauck; Henry Völzke; Karsten Suhre; Hani Najafi-Shoushtari; Jaicy Methew; Vimal Ramachandran; Robin Bülow; Uwe Völker; Hans J Grabe
Journal:  Neuropsychopharmacology       Date:  2019-07-08       Impact factor: 7.853

2.  scAPAatlas: an atlas of alternative polyadenylation across cell types in human and mouse.

Authors:  Xiaoxiao Yang; Yang Tong; Gerui Liu; Jiapei Yuan; Yang Yang
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

3.  MicroRNA-26a/b and their host genes synergistically regulate triacylglycerol synthesis by targeting the INSIG1 gene.

Authors:  Hui Wang; Jun Luo; Tianying Zhang; Huibin Tian; Yue Ma; Huifen Xu; Dawei Yao; Juan J Loor
Journal:  RNA Biol       Date:  2016-03-22       Impact factor: 4.652

4.  Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.

Authors:  Sven H Loosen; Mirco Castoldi; Markus S Jördens; Sanchary Roy; Mihael Vucur; Jennis Kandler; Linda Hammerich; Raphael Mohr; Frank Tacke; Tom F Ulmer; Ulf P Neumann; Tom Luedde; Christoph Roderburg
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

5.  miRNAs modified by dietary lipids in Caco-2 cells. A microarray screening.

Authors:  Lidia Daimiel; Jose M Ordovás; Alberto Dávalos
Journal:  Genom Data       Date:  2015-06-09

Review 6.  Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health.

Authors:  Víctor Micó; Laura Díez-Ricote; Lidia Daimiel
Journal:  Int J Mol Sci       Date:  2016-02-26       Impact factor: 5.923

7.  Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model.

Authors:  Hualin Wang; Yang Shao; Fahu Yuan; Han Feng; Na Li; Hongyu Zhang; Chaodong Wu; Zhiguo Liu
Journal:  Biomed Res Int       Date:  2017-06-12       Impact factor: 3.411

Review 8.  Effect of Dietary Fatty Acids on MicroRNA Expression Related to Metabolic Disorders and Inflammation in Human and Animal Trials.

Authors:  Karla MacDonald-Ramos; Alejandra Martínez-Ibarra; Adriana Monroy; Juan Miranda-Ríos; Marco Cerbón
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

9.  Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.

Authors:  Taisuke Imamura; Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Wataru Okajima; Takuma Ohashi; Jun Kiuchi; Keiji Nishibeppu; Hirotaka Konishi; Atsushi Shiozaki; Ryo Morimura; Hisashi Ikoma; Toshiya Ochiai; Kazuma Okamoto; Hiroki Taniguchi; Eigo Otsuji
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

Review 10.  Pleiotropic functions of miR107 in cancer networks.

Authors:  Zhiying Luo; Yi Zheng; Wei Zhang
Journal:  Onco Targets Ther       Date:  2018-07-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.